Clinical Efficacy of α1-Adrenargic Receptor Antagonist Naftopidil 75 mg/day in Patients with Benign Prostatic Hyperplasia
Author:
Publisher
Wiley
Subject
Urology,Neurology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1757-5672.2010.00072.x/fullpdf
Reference19 articles.
1. The impact of lower urinary tract symptoms and comorbidities on quality of life: The BACH and UREPIK studies;Robertson;BJU Int,2007
2. The standardization of terminology of lower urinary tract function: Report from the standardization sub-committee of the international continence society;Abrams;Neurourol Urodyn,2002
3. Combination treatment with propiverine hydrochloride plus doxazosin controlled release gastrointestinal therapeutic system formulation for overactive bladder and coexisting benign prostatic obstruction: A prospective, randomized, controlled multicenter study;Lee;J Urol,2005
4. Clinical efficacy of α1-blocker naftopidil in patients with overactive bladder associated with benign prostatic hyperplasia;Kakizaki;LUTS,2009
5. Comparison of 25 and 75 mg/day naftopidil for lower urinary tract symptoms associated with benign prostatic hyperplasia: A prospective, randomized controlled study;Yokoyama;Int J Urol,2006
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Subtype Selectivity in Search of Potent Hypotensive Agents among 5,5-Dimethylhydantoin Derived α1-Adrenoceptors Antagonists;International Journal of Molecular Sciences;2023-11-22
2. Influence of Naftopidil on Plasma Monoamine Levels and Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia;LUTS: Lower Urinary Tract Symptoms;2014-11-06
3. Effect of naftopidil, an alpha1D/A-adrenoceptor antagonist, on the urinary bladder in rats with spinal cord injury;Life Sciences;2013-05
4. Naftopidil for the treatment of urinary symptoms in patients with benign prostatic hyperplasia;Therapeutics and Clinical Risk Management;2011-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3